Verified earnings results

ARS Pharmaceuticals Q3 2026 Earnings Results

Direct answer

ARS Pharmaceuticals reported Q3 2026 results on November 5, 2026.

Revenue was 37,710,000. EPS missed the estimate by 11.15%.
The result is verified against Verified earnings source.
Verified earnings source

Get free ARS Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Earnings date
November 5, 2026
Reported timing
After the US market closes
EPS estimate
-0.3239
Reported EPS
-0.36
Revenue
37,710,000
EPS surprise
EPS missed the estimate by 11.15%.

Read the frequently asked questions.

When did ARS Pharmaceuticals report Q3 2026 earnings?

ARS Pharmaceuticals reported on November 5, 2026. The reported timing was after the us market closes.

What is the available EPS estimate for ARS Pharmaceuticals?

The verified record provides an EPS estimate of -0.3239.

Has ARS Pharmaceuticals reported the Q3 2026 result?

Revenue was 37,710,000. EPS missed the estimate by 11.15%.

Which source supports this ARS Pharmaceuticals earnings record?

The earnings record identifies Verified earnings source as its source. Missing values are not estimated.